Technologies communicantes et aide à la gestion du diabète de type 1

If the Diabeo™ system has already demonstrated its effectiveness in Télédiab 1 validation study, it is now necessary to demonstrate that this efficacy is sustainable for a large population of patients and that the system is economically profitable, a prerequisite for its implementation for all patients with T1D who wish to use it. That is the purpose of the French national multicenter study Télésage which should start soon in a population of 700 diabetic patients over a period of 2 years. In addition to the expected metabolic and economic benefits, this study should assess the feasibility and the effectiveness of a new healthcare organization involving specialized nurses to insure, in collaboration with the physician, the monitoring of the data through a protocol of interprofessional cooperation submitted to the French National Health Authority (HAS), and validated by the French Regional Health Agency (ARS). It should be checked that such an organization, which give to the physician the ability to focus his intervention on patients who have the most difficulties to cope with diabetes and to delegate in the same time a number of tasks, is a solution to the insufficiency in health care organization and that it will finally allow an optimization of healthcare.